Concord Drugs Closes Trading Window for Q1 FY27 Results

Concord Drugs Ltd has announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter ending June 30, 2026. This measure, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, restricts directors, designated employees, insiders, and their immediate relatives from trading in the company's securities during this period. The specific date of the board meeting to consider these results will be communicated separately.